Genitourinary Radiology: Page 20

SNMMI 2020: Radionuclide treatment paves way for immunotherapy
By Brian Casey
Could the administration of an yttrium-90-based radionuclide improve the performance of immunotherapy for prostate cancer? That's the suggestion of an animal study presented at this week's Society of Nuclear Medicine and Molecular Imaging (SNMMI) virtual meeting.
July 13, 2020
2020 07 14 17 49 4486 2020 07 14 Radionuclide Therapy 20200714174027
RefleXion, Telix partner on high-risk cancer treatments
By AuntMinnie.com staff writers
Radiation therapy equipment developer RefleXion Medical and radiopharmaceutical company Telix Pharmaceuticals are investigating the clinical utility of combining their technologies for improving treatments for high-risk prostate and aggressive kidney cancers.
July 7, 2020
2020 03 12 17 01 2761 Reflexion Astro 2019 400
AI could help radiologists better detect kidney cancer
By Kate Madden Yee
Artificial intelligence (AI) used with CT data could help abdominal radiologists better identify and classify kidney cancer, according to a presentation delivered at the recent virtual annual meeting of the Society for Imaging Informatics in Medicine.
July 5, 2020
2016 08 23 17 04 30 620 Kidney 400
ViewRay highlights results from prostate cancer study
By AuntMinnie.com staff writers
Image-guided radiation therapy vendor ViewRay is highlighting the results of a clinical study on the use of its MR-guided radiation therapy technology for treating men with prostate cancer.
June 24, 2020
2019 09 17 17 11 0207 Viewray Astro 2019
ITM signs supply deals with Point Biopharma
By AuntMinnie.com staff writers
German radiopharmaceutical group ITM Isotopen Technologien München has signed supply agreements with radiopharmaceutical Point Biopharma for ITM's EndolucinBeta radiopharmaceutical precursor.
June 23, 2020
2016 08 24 09 43 13 537 Hands Shaking V3 400
Exact Imaging taps EDAP as exclusive distributor
By AuntMinnie.com staff writers
Ultrasound technology developer Exact Imaging has named French therapeutic ultrasound firm EDAP as the sole distributor of its ExactVu microultrasound system in the U.S. market.
June 22, 2020
2019 12 19 00 53 5252 Hands Shaking Deal 400
Caution indicated with new GBCAs for kidney patients
By Kate Madden Yee
Even though the occurrence of nephrogenic systemic fibrosis after exposure to gadolinium-based contrast agents (GBCAs) in patients with impaired kidney function is rare, clinicians should be cautious when using these agents in this population, according to a study published June 22 in the Annals of Internal Medicine.
June 22, 2020
2017 03 21 11 45 55 23 Gadolinium2 400
Lantheus completes Progenics purchase
By AuntMinnie.com staff writers
Lantheus Holdings, parent company of Lantheus Medical Imaging, has completed its purchase of oncology drug developer Progenics Pharmaceuticals.
June 21, 2020
2016 08 24 09 43 13 537 Hands Shaking V3 400
Blue Earth, PETNet ink new supply deal
By AuntMinnie.com staff writers
Bracco molecular imaging subsidiary Blue Earth Diagnostics and Siemens Healthineers subsidiary PETNet Solutions have signed a new commercial supply contract for Blue Earth's Axumin radiopharmaceutical and its investigational radiohybrid prostate-specific membrane antigen imaging agent, rhPSMA-7.3 (F-18).
June 15, 2020
2019 12 19 00 53 5252 Hands Shaking Deal 400
Cryoablation comparable to surgery for kidney cancer
By AuntMinnie.com staff writers
Percutaneous cryoablation is comparable to surgery for treating kidney cancer, offering similar 10-year survival rates and lower rates of complications, according to a study published June 9 in Radiology.
June 9, 2020
2016 08 23 17 04 30 620 Kidney 400
Pay attention to patient portals
By AuntMinnie.com staff writers
Patients appreciate getting imaging results both via direct provider contact and via electronic patient portals – but they may have less understanding of advanced imaging results when they receive them online, according to a study published April 29 in the Journal of the American College of Radiology.
April 29, 2020
2018 05 22 21 54 4018 Computer Typing 400
PI-RADS falls short of prostate MRI expectations
By Wayne Forrest
The Prostate Imaging Reporting and Data System (PI-RADS) might not be the perfect tool when it comes to using MRI to confirm suspected cases of prostate cancer, according to a study published April 21 in Radiology.
April 21, 2020
2019 04 17 20 48 2514 Prostate 3 D 400
Previous Page
Page 20 of 93
Next Page